Investing

Many Monday Pre-Market Downgrades (CEG, FIS, FISV, DNA, KBW, NKE, PSO, SHW, SWIR, SWK, WERN, WIT)

These are among the top analyst Downgrades or negative analyst calls affecting shares this Monday morning in pre-market trading:

  • Constellation Energy (NYSE: CEG) Downgraded to Underperform at Jefferies.
  • Fidelity National (NYSE: FIS) Cut to Perform at Oppenheimer.
  • Fiserv (NASDAQ: FISV) Cut to Perform at Oppenheimer.
  • Genentech (NYSE: DNA) Raised to Overweight at Lehman.
  • KBW (NYSE: KBW) Cut to Market Perform at FBR.
  • Nike (NYSE: NKE) Cut to Neutral at HSBC.
  • Pearson plc (NYSE: PSO) Cut to Sell at Deutsche Bank.
  • Satyam Computer Services (NYSE: SAY) Cut to Equal Weight at Morgan Stanley; Cut to Underperform at Credit Suisse.
  • Sherwin Williams (NYSE: SHW) Cut to Sell at Goldman Sachs.
  • Sierra Wireless (NASDAQ: SWIR) Target cut to $20 from $25 at CIBC.
  • Stanley Works (NYSE: SWK) Cut to Hold at Deutsche Bank.
  • Werner Enterprises (NASDAQ: WERN) Cut to Sell at UBS.
  • WIPRO (NYSE: WIT) Cut to Underperform at Credit Suisse.

Jon C. Ogg
July 21, 2008

100 Million Americans Are Missing This Crucial Retirement Tool

The thought of burdening your family with a financial disaster is most Americans’ nightmare. However, recent studies show that over 100 million Americans still don’t have proper life insurance in the event they pass away.

Life insurance can bring peace of mind – ensuring your loved ones are safeguarded against unforeseen expenses and debts. With premiums often lower than expected and a variety of plans tailored to different life stages and health conditions, securing a policy is more accessible than ever.

A quick, no-obligation quote can provide valuable insight into what’s available and what might best suit your family’s needs. Life insurance is a simple step you can take today to help secure peace of mind for your loved ones tomorrow.

Click here to learn how to get a quote in just a few minutes.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.